NCT00604019View on ClinicalTrials.gov

Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock

PHASE3CompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Septic Shock
Interventions
DRUG

Dopamine

Dopamine 5-20 mcg/kg/min to pre-determined max of 20

DRUG

Norepinephrine

Norepinephrine 5-20 mcg/min, to a pre-determined max of 20

Trial Locations (1)

60612

RUSH University Medical Center, Chicago

All Listed Sponsors
lead

Rush University Medical Center

OTHER

NCT00604019 - Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock | Biotech Hunter | Biotech Hunter